The Advisory Committee of the Swedish MPA recommends RescueFlow for approval
The Advisory Committee of the Swedish Medical Products Agency recommends RescueFlow® for approval. The Advisory Committee of the MPA has, with an addition to the product information, recommended the approval of BioPhausia´s product RescueFlow® for marketing in Sweden. RescueFlow® is intended for initial treatment of hypotension due to traumatic injury. BioPhausia will use the mutual recognition procedure for registration in the other EU countries. These countries are expected to approve the product, based on MPA´s approval and assessment, during the first half of 1999. Company President